Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 2.020
+0.030 (1.51%)
Aug 10, 2026, 10:38 AM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 229.39 million as of August 10, 2026. Its market cap has increased by 98.25% in one year.
Market Cap
229.39M
Enterprise Value
201.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.02
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 229.39M, an increase of 143.22%. That is a compound annual growth rate of 12.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 229.39M | 75.96% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 377.24M |
| Auxly Cannabis Group | 284.73M |
| Aurora Cannabis | 258.30M |
| TerrAscend | 221.34M |
| Organigram Global | 191.45M |
| Cannara Biotech | 190.65M |
| BioSyent | 177.18M |
| Medexus Pharmaceuticals | 157.67M |